| 抗肝纤维化相关药物研究现状 |
| |
| 引用本文： | 李永纲,张健.抗肝纤维化相关药物研究现状[J].传染病信息,2010,23(3):190-192. |
| |
| 作者姓名： | 李永纲 张健 |
| |
| 作者单位： | 解放军第三○二医院中西医结合肝病诊疗与研究中心,北京,100039;解放军第三○二医院肝纤维化无创诊疗中心,北京,100039 |
| |
| 摘 要： | 笔者对近年来具有抗肝纤维化作用的药物，如针对病因及抗氧化治疗的药物，以抑制肝星状细胞活化、增生、凋亡和促进胶原降解为靶向的药物，以及中药复方制剂的研究现状进行简要综述。
|
| 关 键 词： | 肝纤维化 抗病毒药 超氧化物类 肝星状细胞 胶原 |
Antifibrotic agents for the treatment of liver diseases |
| |
| LI Yong-gang,ZHANG Jian.Antifibrotic agents for the treatment of liver diseases[J].Infectious Disease Information,2010,23(3):190-192. |
| |
| Authors: | LI Yong-gang ZHANG Jian |
| |
| Institution: | (Liver Disease Center for Combined TCM and Western Medicine, 302 Hospital of PLA, Beijing 100039, China ) |
| |
| Abstract: | This review focuses on the current progress of antifibrotic agents for the treatment of liver diseases, such as antiviral agents, antioxidants, drugs with the target of inhibiting the activation, proliferation and apoptosis of hepatic stellate cells, and stimu- lating collagen degradation, and compound preparations of traditional Chinese medicine. |
| |
| Keywords: | liver fibrosis antiviral agents superoxides hepatic stellate cells collagen |
| 本文献已被 维普 万方数据 等数据库收录！ |
|
